Hemo Organic Limited (BOM:524590)
India · Delayed Price · Currency is INR 21.85
0.00 (0.00%)
At close: Oct 26, 2026
Hemo Organic Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 0.13 | 0.11 | 0.09 | 1.29 | 1.17 | 0.09 |
Cash & Short-Term Investments | 0.13 | 0.11 | 0.09 | 1.29 | 1.17 | 0.09 |
Cash Growth | 2460.00% | 25.29% | -93.23% | 10.29% | 1163.13% | -32.42% |
Accounts Receivable | 23.58 | 23.89 | 25.18 | 0.83 | 0.59 | 0.59 |
Other Receivables | 11.06 | 6.89 | 7.52 | 7.1 | 0.07 | - |
Receivables | 42.34 | 39.39 | 32.69 | 7.93 | 0.66 | 0.59 |
Inventory | 5.08 | 5.08 | 14.16 | - | 0.15 | 0.17 |
Other Current Assets | - | - | - | - | 0.04 | 0.11 |
Total Current Assets | 47.55 | 44.58 | 46.94 | 9.22 | 2.02 | 0.97 |
Property, Plant & Equipment | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 |
Long-Term Deferred Tax Assets | - | - | 2.79 | 1.41 | 1.41 | 1.41 |
Total Assets | 47.58 | 44.61 | 49.76 | 10.64 | 3.44 | 2.39 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 1.92 | 15.61 | 36.33 | 1.06 | 1.07 | 1.11 |
Accrued Expenses | 0.03 | 0.08 | 0.09 | 0.05 | - | - |
Other Current Liabilities | 0.2 | 0.18 | 0.06 | 0.31 | 2.53 | 0.89 |
Total Current Liabilities | 2.15 | 15.87 | 36.47 | 1.42 | 3.6 | 2.01 |
Long-Term Debt | 12.91 | 27.41 | 14.8 | 12.38 | 0.35 | 0.35 |
Long-Term Deferred Tax Liabilities | 0.01 | 0.01 | 0.01 | - | - | - |
Total Liabilities | 15.07 | 43.28 | 51.27 | 13.8 | 3.96 | 2.36 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 68.66 | 34.66 | 34.66 | 34.66 | 34.66 | 34.66 |
Retained Earnings | -36.14 | -43.96 | -36.17 | -37.81 | -35.17 | -34.62 |
Comprehensive Income & Other | - | 10.63 | - | - | - | - |
Shareholders' Equity | 32.52 | 1.33 | -1.52 | -3.15 | -0.51 | 0.03 |
Total Liabilities & Equity | 47.58 | 44.61 | 49.76 | 10.64 | 3.44 | 2.39 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 12.91 | 27.41 | 14.8 | 12.38 | 0.35 | 0.35 |
Net Cash (Debt) | -12.78 | -27.3 | -14.71 | -11.09 | 0.81 | -0.26 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -3.59 | -7.88 | -4.24 | -3.20 | 0.23 | -0.07 |
Filing Date Shares Outstanding | 3.63 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 |
Total Common Shares Outstanding | 3.63 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 |
Working Capital | 45.4 | 28.71 | 10.47 | 7.8 | -1.59 | -1.04 |
Book Value Per Share | 8.97 | 0.38 | -0.44 | -0.91 | -0.15 | 0.01 |
Tangible Book Value | 32.52 | 1.33 | -1.52 | -3.15 | -0.51 | 0.03 |
Tangible Book Value Per Share | 8.97 | 0.38 | -0.44 | -0.91 | -0.15 | 0.01 |
Machinery | - | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 |